| __timestamp | Johnson & Johnson | Summit Therapeutics Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 8494000000 | 15635076 |
| Thursday, January 1, 2015 | 9046000000 | 23943601 |
| Friday, January 1, 2016 | 9095000000 | 23689111 |
| Sunday, January 1, 2017 | 10554000000 | 41006114 |
| Monday, January 1, 2018 | 10775000000 | 51379106 |
| Tuesday, January 1, 2019 | 11355000000 | 32705593 |
| Wednesday, January 1, 2020 | 12340000000 | 53274000 |
| Friday, January 1, 2021 | 14277000000 | 85352000 |
| Saturday, January 1, 2022 | 14135000000 | 51999000 |
| Sunday, January 1, 2023 | 15048000000 | 59471000 |
| Monday, January 1, 2024 | 17232000000 |
Unleashing insights
In the ever-evolving landscape of pharmaceutical innovation, research and development (R&D) spending is a critical indicator of a company's commitment to future growth. Over the past decade, Johnson & Johnson and Summit Therapeutics Inc. have demonstrated contrasting approaches to R&D investment.
From 2014 to 2023, Johnson & Johnson's R&D expenses surged by approximately 77%, reflecting their robust pipeline and commitment to innovation. In 2023, their R&D spending reached a peak, showcasing their strategic focus on long-term growth. In contrast, Summit Therapeutics Inc., a smaller player, exhibited a more modest increase of around 280% in R&D expenses over the same period, highlighting their agile approach to niche markets.
This comparison underscores the diverse strategies within the pharmaceutical industry, where both giants and emerging companies play pivotal roles in shaping the future of healthcare.
Johnson & Johnson vs Merck & Co., Inc.: Strategic Focus on R&D Spending
R&D Spending Showdown: Johnson & Johnson vs Bristol-Myers Squibb Company
Research and Development Investment: Johnson & Johnson vs Pfizer Inc.
Who Prioritizes Innovation? R&D Spending Compared for Johnson & Johnson and Zoetis Inc.
Research and Development Investment: Johnson & Johnson vs Catalyst Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Johnson & Johnson and Celldex Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Vertex Pharmaceuticals Incorporated and Summit Therapeutics Inc.
Research and Development Investment: Summit Therapeutics Inc. vs Alkermes plc
R&D Insights: How Summit Therapeutics Inc. and ADMA Biologics, Inc. Allocate Funds
Summit Therapeutics Inc. vs Arrowhead Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Summit Therapeutics Inc. and MannKind Corporation
Research and Development: Comparing Key Metrics for Summit Therapeutics Inc. and MiMedx Group, Inc.